scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1006923174 |
P356 | DOI | 10.1038/LEU.2008.14 |
P698 | PubMed publication ID | 18273045 |
P50 | author | Thoas Fioretos | Q41520261 |
Ioannis Panagopoulos | Q41934299 | ||
Henrik Lilljebjörn | Q43062751 | ||
Josef Davidsson | Q56065851 | ||
P2093 | author name string | B Johansson | |
P2860 | cites work | Mutations of the BRAF gene in human cancer | Q27860760 |
Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia | Q28305210 | ||
Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukemias: a Nordic series of 24 cases and review of the literature | Q36996304 | ||
BRAF mutations in non-Hodgkin's lymphoma | Q38603361 | ||
Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses). | Q40482674 | ||
Alterations of RAS signalling in Chinese multiple myeloma patients: absent BRAF and rare RAS mutations, but frequent inactivation of RASSF1A by transcriptional silencing or expression of a non-functional variant transcript. | Q40616537 | ||
The T1790A BRAF mutation (L597Q) in childhood acute lymphoblastic leukemia is a functional oncogene | Q42827990 | ||
Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia | Q46799049 | ||
Mutations of FLT3, NRAS, KRAS, and PTPN11 are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia. | Q46971359 | ||
Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene. | Q51903901 | ||
BRAF mutations in acute leukemias | Q53648461 | ||
Mutations in the BRAF and N-ras genes in childhood acute lymphoblastic leukaemia. | Q53796172 | ||
RAF/RAS oncogenes and mismatch-repair status | Q57281056 | ||
BRAF gene is not mutated in plasma cell leukemia and multiple myeloma | Q73833899 | ||
Mutation of BRAF is uncommon in AML FAB type M1 and M2 | Q78800433 | ||
The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations | Q80123655 | ||
P433 | issue | 8 | |
P304 | page(s) | 1619-1621 | |
P577 | publication date | 2008-02-14 | |
P1433 | published in | Leukemia | Q6534498 |
P1476 | title | BRAF mutations are very rare in B- and T-cell pediatric acute lymphoblastic leukemias | |
P478 | volume | 22 |
Q34044770 | B-Raf regulation of integrin α4β1-mediated resistance to shear stress through changes in cell spreading and cytoskeletal association in T cells |
Q43148954 | BRAF V600E and MAP2K1 mutations in hairy cell leukemia and splenic marginal zone lymphoma cases |
Q24609980 | BRAF mutations in hairy-cell leukemia |
Q44195415 | Genetic homogeneity of adult Langerhans cell histiocytosis lesions: Insights from BRAFV600E mutations in adult populations |
Q36862768 | Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response |
Q27852887 | RAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are associated with second-hand smoking exposures |
Q38227885 | Ras/Raf/MEK/ERK Pathway Activation in Childhood Acute Lymphoblastic Leukemia and Its Therapeutic Targeting |
Q37865381 | Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. |
Search more.